Skip to content

Predictors of the Ability to Protect the Airway in Long-term Ventilated Patients

Determining Predictors of Adequate Upper Airway Function in Long-term Ventilated Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01618240
Enrollment
30
Registered
2012-06-13
Start date
2011-01-31
Completion date
2012-04-30
Last updated
2014-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Swallowing Disorder, Aspiration, Long Term Ventilation

Keywords

FEES, PAS, VPSR, MRC

Brief summary

First part of a 2 part study with the same IRB protocol #, and labeled 'A'. Investigators hypothesized that clinical muscle strength assessment (manual muscle testing) predicts the ability to protect the airway during swallowing in long-term ventilated subjects. More specifically, the investigators hypothesized that low muscle strength is associated with the inability to clear secretions from the peri-laryngeal area (valleculae and pyriform sinus residue scale (VPSR scale \[NRS: 0-4\] of \> 1) and entering the materials into airway (PAS scale \[1-8\]\> 1), which should predispose to endotracheal aspiration.

Interventions

MRC score (0-60) is a clinical assessment of muscle power on abduction of the arm, flexion of the forearm, extension of the wrist, flexion of the leg, extension of the knee and dorsal flexion of the foot with the score of (0-5) on each measurement

A mechanical ventilator is used to assist or replace spontaneous breathing.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients admitted to the Respiratory Acute Care Unit and Surgical Intensive Care Unit, units with a mixed collection of long term ventilated patients in a major academic teaching hospital. 2. Age over 18 years. 3. Long-term ventilated patients (\>10 days) with tracheotomies

Exclusion criteria

1. Decreased level of consciousness as defined by a Richmond Agitation Sedation Scale (RASS) of 0. 2. Non-cooperative patient, CAM score positive for delirium. 3. For women: pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Muscle StrengthWithin 24 hours of fiberoptic endoscopic evaluation of swallowWe use Medical Research Council (MRC) scale (0-60) to evaluate the degree of muscle weakness in the tracheostomized patients.

Secondary

MeasureTime frame
Number of Patients With Muscle Weakness (MRC<48) Who Developed Clinical AspirationWithin 3 month follow-up

Countries

United States

Participant flow

Participants by arm

ArmCount
Baseline Population
Thirty long-term ventilated patients admitted in two intensive care units at Massachusetts General Hospital.
30
Total30

Baseline characteristics

CharacteristicBaseline Population
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
7 Participants
Age, Categorical
Between 18 and 65 years
23 Participants
Age, Continuous55 years
STANDARD_DEVIATION 14
Region of Enrollment
United States
30 participants
Sex: Female, Male
Female
14 Participants
Sex: Female, Male
Male
16 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 30
serious
Total, serious adverse events
0 / 30

Outcome results

Primary

Muscle Strength

We use Medical Research Council (MRC) scale (0-60) to evaluate the degree of muscle weakness in the tracheostomized patients.

Time frame: Within 24 hours of fiberoptic endoscopic evaluation of swallow

ArmMeasureGroupValue (NUMBER)
Muscle Strength MeasurementMuscle StrengthClinically significant muscle weakness (<48)20 participants
Muscle Strength MeasurementMuscle StrengthNo clinically significant muscle weakness (>=48)10 participants
Secondary

Number of Patients With Muscle Weakness (MRC<48) Who Developed Clinical Aspiration

Time frame: Within 3 month follow-up

ArmMeasureGroupValue (NUMBER)
Muscle Strength MeasurementNumber of Patients With Muscle Weakness (MRC<48) Who Developed Clinical AspirationSymptomatic aspiration14 participants
Muscle Strength MeasurementNumber of Patients With Muscle Weakness (MRC<48) Who Developed Clinical AspirationNo symptomatic aspiration6 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026